Product Code: ETC9961636 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Candidiasis Therapeutics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Candidiasis Therapeutics Market - Industry Life Cycle |
3.4 United States (US) Candidiasis Therapeutics Market - Porter's Five Forces |
3.5 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By Symptom Type, 2021 & 2031F |
3.7 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United States (US) Candidiasis Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Candidiasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of candidiasis infections in the United States |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of candidiasis |
4.2.3 Technological advancements leading to the development of more effective therapeutics |
4.3 Market Restraints |
4.3.1 High costs associated with candidiasis therapeutics |
4.3.2 Limited availability of approved treatment options |
4.3.3 Regulatory challenges in the approval process for new therapeutics |
5 United States (US) Candidiasis Therapeutics Market Trends |
6 United States (US) Candidiasis Therapeutics Market, By Types |
6.1 United States (US) Candidiasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Oropharyngeal Candidiasis, 2021- 2031F |
6.1.4 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Genital Candidiasis, 2021- 2031F |
6.1.5 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Invasive Candidasis, 2021- 2031F |
6.2 United States (US) Candidiasis Therapeutics Market, By Symptom Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Oral Thrush, 2021- 2031F |
6.2.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Fatigue, 2021- 2031F |
6.2.4 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Urinary Tract Infection (UTI), 2021- 2031F |
6.3 United States (US) Candidiasis Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 United States (US) Candidiasis Therapeutics Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.5 United States (US) Candidiasis Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 United States (US) Candidiasis Therapeutics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 United States (US) Candidiasis Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 United States (US) Candidiasis Therapeutics Market Import-Export Trade Statistics |
7.1 United States (US) Candidiasis Therapeutics Market Export to Major Countries |
7.2 United States (US) Candidiasis Therapeutics Market Imports from Major Countries |
8 United States (US) Candidiasis Therapeutics Market Key Performance Indicators |
8.1 Number of diagnosed candidiasis cases in the United States |
8.2 Adoption rate of new candidiasis therapeutics |
8.3 Research and development investment in candidiasis treatment technologies |
9 United States (US) Candidiasis Therapeutics Market - Opportunity Assessment |
9.1 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By Symptom Type, 2021 & 2031F |
9.3 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United States (US) Candidiasis Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Candidiasis Therapeutics Market - Competitive Landscape |
10.1 United States (US) Candidiasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Candidiasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |